Ownership history in Walleye Capital LLC · 8 quarters on record
This page tracks every 13F SEC filing in which Walleye Capital LLC reported a position in RHYTHM PHARMACEUTICALS INC (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 50,181 | +27,181 | +118.2% | 0.02% | $5.1M | $100.99 |
| 2025 Q1 | REDUCED | 23,000 | -12,828 | -35.8% | 0.01% | $1.2M | $52.97 |
| 2025 Q1 | REDUCED | 35,828 | -108,514 | -75.2% | 0.01% | $1.9M | $52.97 |
| 2024 Q4 | REDUCED | 144,342 | -251,199 | -63.5% | 0.02% | $8.1M | $55.98 |
| 2023 Q2 | ADDED | 395,541 | +257,772 | +187.1% | 0.02% | $6.5M | $16.49 |
| 2023 Q1 | REDUCED | 137,769 | -53,604 | -28.0% | 0.04% | $2.5M | $17.84 |
| 2022 Q3 | ADDED | 191,373 | +141,528 | +283.9% | 0.09% | $4.7M | $24.50 |
| 2021 Q3 | INITIATED | 49,845 | — | — | 0.02% | $651K | $13.06 |
As of 2025 Q4 — sorted by position size